STANDARD BIOTLS (LAB)
(Delayed Data from NSDQ)
$1.40 USD
-0.01 (-0.71%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.38 -0.02 (-1.43%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Standard BioTools Inc. has a market cap of $538.61M, which represents its share price of $1.41 multiplied by its outstanding shares number of 381.99M. As a small-cap company, LAB's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LAB 1.40 -0.01(-0.71%)
Will LAB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LAB
Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
LAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
Strength Seen in American Well (AMWL): Can Its 18.8% Jump Turn into More Strength?
Other News for LAB
LAB forms Upper Bollinger Band Walk on September 19
180 Bullish Setup appears for LAB after 4.44% move
200 Day Moving Average Support appears for LAB after 2.17% move
LAB forms 200 Day Moving Average Support on September 16
Standard BioTools Announces Workforce Reduction Plan